Donna Romero has over 20 years of experience in drug discovery and development and pharmaceutical research management. She began her career at the Upjohn Company where she was the inventor of the non-nucleoside reverse transcriptase inhibitor Rescriptor® marketed for the treatment of HIV. Subsequently, she held project team leadership positions on the Cell Cycle and Bacterial Genomics Teams. She has broad experience leading and supervising cross-disciplinary drug discovery teams in multiple therapeutic areas in the Upjohn, Pharmacia, and Pfizer pharmaceutical companies. Since leaving Pfizer in 2007, where she was a Senior Director in Medicinal Chemistry, Donna has been an independent consultant working with a broad array of biotechnology companies and with the Spinal Muscular Atrophy Lead Development team for the NINDS.